School of Medicine
Showing 21-40 of 171 Results
-
Juno Obedin-Maliver
Associate Professor of Obstetrics and Gynecology (Gynecology & Gynecologic Specialties/Generalist) and, by courtesy, of Epidemiology and Population Health
BioJuno Obedin-Maliver, MD, MPH, MAS, FACOG (she/her) is an Associate Professor in the Department of Obstetrics and Gynecology at Stanford University School of Medicine.
Dr. Juno Obedin-Maliver is a board-certified obstetrician/gynecologist who provides excellent clinical care, while advancing scientific knowledge through her research, and supporting personal and professional development as a physician coach.
She practices full-spectrum gynecology including outpatient, in-patient, operative, and emergency care services. This specifically includes collaborative management of cervical dysplasia and abnormal pap smears, abnormal uterine bleeding, contraception and family planning, pelvic pain, abnormal discharge, sexually transmitted infection testing and treatment, and more. She specializes in the gynecological and reproductive health care needs of sexual and gender minority people which include but are not limited to lesbian, gay, bisexual, transgender, queer and questioning (LGBTQ+) people. This interest and experience drives her research interests towards promoting the health and well-being and equity of LGBTQ people.
Dr. Obedin-Maliver, is the Co-Director of The PRIDE Study (pridestudy.org), a multi-site online prospective longitudinal cohort of sexual and gender minority individuals based at Stanford. She also serves on the medical advisory board of the University of California San Francisco Center of Excellence for Transgender Health and is helping to author the next version of the World Professional Association for Transgender Health (WPATH) Standards of Care. Dr. Obedin-Maliver has also been active in health policy, including involvement in helping to legally redefine consideration of sexually intimate partner status and to remove the Medicare Non-Coverage Determination ruling on gender -affirming surgeries.
Additionally, Dr. Obedin-Maliver continues her long-standing commitment to growth, healing, and empowerment as a Master Certified Physician Development Coach (Physician Coaching Institute, ICF Level I). In her coaching, Dr. Obedin-Maliver uses personal and professional development tools, mindfulness, and somatic frameworks to enhance health, agency, and creativity in partnering with individuals to help them achieve their professional goals and design their personal lives. She rejoices in partnering with diverse healthcare providers to use her broad skills to supercharge their authentic learning and growth, especially in times of challenge and resistance.
For more information about her research and career, please see: pridestudy.org and http://med.stanford.edu/obedin-maliver.html -
Jelena Obradović
Professor of Education
Current Research and Scholarly InterestsAdaptation, resilience, and developmental psychopathology of disadvantaged children populations; Stress reactivity and biological sensitivity to contextual influences; Executive function and self-regulatory abilities; Effects of risk, adversity, and social status on children’s development.
-
Michelle Odden
Associate Professor of Epidemiology and Population Health
Current Research and Scholarly InterestsMultilevel - from cells to society - epidemiologic study of healthy aging
-
Marcus Oehlrich, PhD
Masters Student in Biomedical Data Science, admitted Autumn 2025
BioI am a Professor of Finance, Accounting, and Taxation at accadis University of Applied Sciences in Bad Homburg, Germany, and I advise on startups, business valuation, and corporate finance. My consulting projects range from small startups in biotechnology and M&A transactions in the pharmaceutical and biotech sectors to the preparation of the business plan for the IPO of an international music and movie production group.
During my business studies, I became interested in law and medicine (especially cancer research), which is why I continued my education in these fields (including a Master of Science in Pharmaceutical Medicine, a Certificate in Pharmaceutical Law, and an MPH at Harvard T.H. Chan School of Public Health). Subsequently, I have started the M.S. in Biomedical Data Science at the Department of Biomedical Data Science at Stanford University School of Medicine.
I also had the privilege of serving as the CEO of the Institute for German, European, and International Medical Law, Health Law, and Bioethics of the Universities of Heidelberg and Mannheim (IMGB) from 2005 to 2011. At accadis University of Applied Sciences, I am Head of the Health Care Management Research Group and responsible for the Master of Arts in International Health Care Management. From 2010 to 2020, I served as the Honorary Consul of the Republic of San Marino in Frankfurt, Germany.
Most of my publications (12 books and more than 70 articles) are related to business topics. However, I also authored three books on cancer "Internetkompass Krebs [Internet compass cancer]" (Springer 2001), "Recombinant humanized monoclonal antibody Trastuzumab for the treatment of metastatic breast cancer with tumors overexpressing the HER2/neu proto-oncogene: A systematic review" (dissertation.de 2003) and "Krebs vorbeugen und bekämpfen [Preventing and combating cancer: All about prevention, early detection, therapy]" (Reader's Digest 2012). The latter was translated into Polish, Czech, Croatian, Slovenian, and Hungarian. -
Nima Ogabian
Affiliate, The Sean N. Parker Center - Administration
BioI am a 4th-year undergraduate student majoring in Psychology/Pre-Med with a minor in Business Management. Having interdisciplinary interests spanning behavioral science, health, and innovation, my academic work focuses on understanding human behavior, decision-making, and social systems, while considering the neural mechanisms underlying brain function, which I complement with hands-on experience in entrepreneurship and in clinical settings. My long-term goal is to pursue advanced training in medicine, integrating research, clinical insight, and entrepreneurship to develop solutions that improve patient outcomes and global health.
